Publications by authors named "Chigusa Higuchi"

Claim this Profile
P
Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).
Asami Ueno, Yasuhiro Onishi, Koki Mise, Satoshi Yamaguchi, Ayaka Kanno, Chigusa Higuchi

BMJ Open Diabetes Res Care· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of a Series of Surveys on Adverse Reactions to the COVID-19 mRNA-1273 Vaccine at Okayama University.
Naomi Matsumoto, Chigusa Higuchi, Chikara Miyaji, Toshiharu Mitsuhashi, Hideharu Hagiya

Acta Med Okayama· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Two Doses of COVID-19 Vaccine mRNA-1273 for an Individual Previously Vaccinated with Two Doses of an Inactivated Vaccine CoronaVac That Has Not Been Approved in Japan.
Yoshiaki Iwasaki, Chigusa Higuchi

Acta Med Okayama· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine.
Naomi Matsumoto, Tomoka Kadowaki, Rumi Matsuo, Ayako Sasaki, Chikara Miyaji, Chigusa Higuchi

J Epidemiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating GPIHBP1 levels and microvascular complications in patients with type 2 diabetes: A cross-sectional study.
Naoko Kurooka, Jun Eguchi, Kazutoshi Murakami, Shinji Kamei, Toru Kikutsuji, Chigusa Higuchi

J Clin Lipidol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse reactions and attitudes toward vaccines among young populations one month after receiving a second dose of mRNA-1273 in Japan.
Naomi Matsumoto, Chigusa Higuchi, Toshiharu Mitsuhashi, Hideharu Hagiya, Soshi Takao

Glob Health Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2).
Koki Mise, Mariko Imamura, Satoshi Yamaguchi, Mayu Watanabe, Chigusa Higuchi

Front Cardiovasc Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.
Chigusa Higuchi, Atsuko Nakatsuka, Jun Eguchi, Sanae Teshigawara, Motoko Kanzaki

Metabolism· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy.
Mayu Watanabe, Atsuko Nakatsuka, Kazutoshi Murakami, Kentaro Inoue, Takahiro Terami, Chigusa Higuchi

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease.
Yuko Kurose, Jun Wada, Motoko Kanzaki, Sanae Teshigawara, Atsuko Nakatsuka, Chigusa Higuchi

BMC Nephrol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis